CELULAS 2010 · CeTMMo/EM/2010
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A multicenter, randomized, double-blind, partially crossover phase I/II clinical trial evaluating the safety and feasibility of systemic therapy with autologous bone marrow-derived mesenchymal cells in patients with multiple sclerosis. EudraCT: 2010-023368-42.
Sponsor: FPS
Phase: I
Area: Neuroimmunology